Clin Pharmacol Ther 111(1):272282 Ueda P, Wintzell V, Melbye M, Eliasson B, Sderling J, Gudbjrnsdottir S, Pasternak B (2023) Use of DPP4 inhibitors and GLP-1 receptor agonists and risk of intestinal obstruction: Scandinavian cohort study
Enter the amount of water in milliliters (mL)
Concentration depends on vial size and BAC water volume
However, these agents are associated with increased thyroid cancer risk, and the packaging for these medications in the United States has a boxed warning stating that they are contraindicated in people with a personal or family history of medullary thyroid cancer and in patients with a diagnosis of multiple endocrine neoplasia syndrome type 2
This allows for higher dosing of the active ingredient, which helps maintain a healthy mucosal surface